Back

Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Renal Failure and Cardiovascular Disease ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Kenneth W Mahaffey

Stanford University Medical Center, Stanford (United States of America)

155 More presentations in this session

Presentation thumbnail
Implementation study of CT calcium score in patients with atypical angina pectoris and non-specific thoracic complaints in primary care: rationale, objectives, and design of the CONCRETE study
Miss M. Koopman (Groningen, NL)
Abstract Slides
Presentation thumbnail
Serum uric acid possibly associated with abnormal left ventricular diastolic function in healthy individuals
Doctor C. Liu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Characteristics and health status of patients with and without confirmed HFpEF
Professor C. Deaton (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Evaluating the diagnostic and prognostic value of cardiac biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy
Mr A. Nikhanj (Edmonton, CA)
Abstract Slides
Presentation thumbnail
Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study.
Doctor F. Fioravanti (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources